`TKIR KORONAR SINDROM ST SEGMENTI ELEVATSIYASIZ TASHXISLI BEMORLARNI DAVOLASHDA ANTITROMBOTIK VA ANTIKOAGULYANT DORI VOSITALARINING QO`LLANISHI
##article.subject##:
o’tkir koronar sindrom, temir tanqis anemiya, gemorragik asoratlar xavfi, geparin##article.abstract##
Hozirgi davrda o'tkir koronar sindrom ST segmentini elevatsiyasiz tashxisli bemorlarda antiagregant va antikoagulyantlarni birgalikda qo'llash keng qo'llanmoqda. Biroq, ba'zi hollarda, ST segmentini elevatsiyasiz o'tkir koronar sindrom bilan og'rigan bemorlarda antikoagulyantlarni qo'llash gemorragik asoratlar xavfini oshiradi. Ishning maqsadi qon ketish xavfi yuqori bo'lgan va temir tanqisligi kamqonligi bo'lgan bemorlarni olib borish taktikasini aniqlashdir. ST segmentini elevatsiyasiz o'tkir koronar sindrom tashxisi bilan kardioreanimatsiya bo'limiga yotqizilgan 112 bemorning anamnezi tahlil qilindi. Trombotik va gemorragik asoratlarning rivojlanish chastotasi, shuningdek antikoagulyantlarni qabul qilishni nazarda tutmaydigan terapiya bilan taqqoslaganda ushbu toifadagi bemorlarning prognozi bo'yicha dastlabki temir tanqisligi anemiyasini davolash fonida geparin bilan etarli antikoagulyant davolashning samaradorligi va xavfsizligi o'rganildi. Ishning prospektiv qismiga 35 bemor kirdi. ST segmentini elevatsiyasiz o'tkir koronar sindrom bilan og'rigan bemorlarda trombotik asoratlarning yuqori darajasi ko'rsatilgan. ST segmentini elevatsiyasiz o'tkir koronar sindromda trombotik asoratlarning yuqori chastotasi va shu bemorlarda antitrombotik terapiyaning muhimligi aniqlandi. ST segmentini elevatsiyasiz o'tkir koronar sindromda temir tanqis anemiyaning ko’p uchraganligi sababli qon ketish xavf omillarini baholash ( HAS- BLEND shkalasi) va keying olib borish taktikasini aniqlashni taqozo etadi.
Библиографические ссылки
Alexander K. Р., Peterson E. D. Minimizing the risks of anticoagulants and platelet inhibitors. Circulation 2010; 121 (17): 1960—1970.
Anand I., McMurray J. J., Whitmore J. Anemia and its relationship to clinical outcome in heart failure. Circulation 2014; 110: 149—154.
Eikelboom J. W., Mehta S. R., Anand S. S. et al. impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2016; 114: 774—782.
Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996; 347 (9001): 561—568.
Ix J. H., de Boer I. H., Wassel C. L. et al. Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study. Circulation 2020; 121 (11): 1295—1303.
Lagerqvist В., Kontny F. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 2016; 368: 998—1004.
Meneveau N., Schiele F., Seronde M. F. et al. Anemia for risk assessment of patients with acute coronary syndromes. Am. J. Cardiol. 2019; 103 (4): 442—447.
Musted S. Evidence-based prescribing and adherence to antiplatelet therapy-how much difference do they make to patients with atherothrombosis? Int. J. Cardiol. 2019; 134 (2): 150—159.
Nancy M., La Pointe A., Pharm D. et al. Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes. Arch. Internj. Med. 2017; 167 (14): 1539—1544.
Oler A., Whooley M. A., Oler J., Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angi-na. A meta-analysis. J.A.M.A. 1996; 276:811—815.
Subherwal S., Bach R. G., Chen A. Y. et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress AD verse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation 2019; 119 (14): 1873—1882.
Yang X., Alexander K. P., Chen A. Y. CRUSADE Investigators. The implications of blood transfusions for patients with non-ST segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J. Am. Coll. Cardiol. 2015; 46: 1490—1495.
Van der Hulst R. W., Zandstra D. F., Geraedts A. A. et al. Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury. Intensive Care Med. 2011; 27 (1): 68—73.
